Turkey emerges as a global hotspot for healthcare
20 May 2015 | By Victoria White
Driven by reforms and private investments, Turkey is steadily emerging as one of the hottest healthcare markets in the global arena...
List view / Grid view
News
NIHR launches new Clinical Trials Guide for Trainees
20 May 2015 | By Victoria White
To mark International Clinical Trials Day 2015, the National Institute for Health Research (NIHR) has launched a new Clinical Trials Guide for Trainees.
FDA approves Invega Trinza four-times-a-year treatment for schizophrenia
20 May 2015 | By Victoria White
The FDA have approved Janssen’s New Drug Application (NDA) for the three-month long-acting atypical antipsychotic Invega Trinza...
Dyslipidemia treatment market value will approach $38 billion by 2023
20 May 2015 | By Victoria White
The global treatment market for dyslipidemia will more than double from $15.4 billion in 2013 to an estimated $37.9 billion by 2023, according to GlobalData...
Biogen UK named as one of the best workplaces in the UK by the ‘Great Place to Work’ Institute
19 May 2015 | By Victoria White
Biogen UK has been named as one of the UK’s best workplaces in the Medium Category in the ‘Great Place to Work®’ annual Best Workplaces list...
Debiopharm announces positive Phase III results for triptorelin 6-month formulation in the management of central precocious puberty
19 May 2015 | By Victoria White
Debiopharm has announced the completion of a Phase III study with triptorelin 6-month formulation in 44 patients with central precocious puberty...
pSivida announces positive safety data from Phase III trial of Medidur
19 May 2015 | By Victoria White
pSivida has announced positive safety data from its ongoing assessment of safety data from its Phase III clinical trial of Medidur for posterior uveitis...
Phase II data for GED-0301 in patients with active Crohn’s disease presented at Digestive Disease Week
19 May 2015 | By Victoria White
A post-hoc subgroup analysis of a Phase II trial of Celgene’s GED-0301 in patients with active Crohn's disease was presented at Digestive Disease Week...
‘Imperfect drug penetration’ speeds pathogen resistance
19 May 2015 | By Victoria White
A new study has found that prescribing patients two or more drugs that do not reach the same parts of the body could accelerate pathogen resistance...
New study compares radiotherapy with proton therapy in childhood cancer
19 May 2015 | By Victoria White
Clinicians aiming to compare the use of proton therapy in the treatment of medulloblastoma with conventional photon radiotherapy...
The 68th World Health Assembly opens in Geneva
19 May 2015 | By Victoria White
Angela Merkel addressed delegates on the first morning of the Health Assembly, calling for a new plan to deal with “catastrophes” like the Ebola outbreak...
Regeneron and Sanofi announce positive Phase 2b dupilumab data in asthma
19 May 2015 | By Victoria White
Regeneron and Sanofi have shared positive results from an interim analysis of a pivotal Phase 2b study of dupilumab in adult patients with moderate to-severe asthma, who are uncontrolled despite treatment with inhaled corticosteroids and long-acting beta agonists (ICS/LABA).
Experts share real-world experience with biosimilar infliximab in patients with inflammatory bowel disease
19 May 2015 | By Victoria White
Clinical experience of biosimilar infliximab shows that the treatment is comparable to the reference medicinal product in terms of efficacy and safety...
CPhI Worldwide announces members of its 2015 Expert Panel
18 May 2015 | By Victoria White
CPhI Worldwide has announced its Expert Panel for CPhI Worldwide 2015 ahead of the eagerly anticipated annual report (3rd edition)...
First patient dosed in Phase 2 study of tipifarnib in advanced cancers with HRAS mutations
18 May 2015 | By Victoria White
The first patient has been dosed in the Phase 2 clinical trial of tipifarnib in patients with locally advanced tumours that carry HRAS mutations...
